cabotegravir (GSK1265744) long-acting parenteral formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for cabotegravir (GSK1265744) long-acting parenteral formulation, covering 2014-04-21 to 2014-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects [Phase 1]